Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT01599533
Eligibility Criteria:
Inclusion Criteria:
* Major subject at the time of the inclusion
* Subject sent in hospitalization or in consultation of surgery vascular for coverage of the first one anévrysme of the sub-renal abdominal aorta degenerative, without anomaly associated by the coeliac aorta, and by the upper diameter in 40mm (according to the criteria of measure recommended for the analysis in echography doppler or in angioscanner).
* subject not presenting contraindication to the realization of the diagnostic examination by aortic angioscanner
* Subject having signed a consent.
Exclusion Criteria:
Subject under age 18
* pregnant Woman
* Subject received in the phase aigue of a break or a fissuring of an AAA under renal
* Subject already operated for a thoracic or abdominal aortic anévrysme
* Subject presenting at least one of the following pathologies:
* heart disorder valvulaire aortic: aortic incapacity of rank superior to 2, tight aortic stenosis, prosthesis valvulaire aortic
* context of bicuspidie station wagon diagnosed on at least 2 parents of the first degree
* of a not degenerative aortopathie anévrysmale bound(connected) in bicuspidie aortic, or: A dissection of type(chap) A or of type(chap) B
* Of a degenerative aortopathie of type anévrysme thoracoabdominal (in particular, affected by the coeliac aorta, defined by the segment enter the diaphragmatique crossing and the renal arteries)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01599533
Study Brief:
Protocol Section:
NCT01599533